Genomic sequencing of pediatric AML
Genomic sequencing has fundamentally transformed the clinical research landscape for pediatric AML, shifting the paradigm from morphology-based classification to molecularly driven precision oncology. Its significance is multi-faceted and profound, encompassing diagnosis, risk stratification, therapeutic intervention, and translational discovery.